or Try an Advanced Search...

    Protein Kinase Inhibitor Stocks List

    Symbol Grade Name % Change
    ALLR F Allarity Therapeutics, Inc. 2.53
    NTBL F Notable Labs, Ltd. -8.00
    PRLD F Prelude Therapeutics Incorporated 1.07
    EXEL F Exelixis, Inc. -0.89
    BBIO F BridgeBio Pharma, Inc. -2.65
    AVBP F ArriVent BioPharma, Inc. 1.50
    PBYI D Puma Biotechnology Inc 6.55
    ACLX D Arcellx, Inc. -0.86
    COGT C Cogent Biosciences, Inc. -3.97
    DAWN B Day One Biopharmaceuticals, Inc. 0.63
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Tyrosine Kinase Biotechnology Biopharmaceutical Enzymes Solid Tumors Tyrosine Kinase Receptors Acute Myeloid Leukemia Cancer Treatment Clinical Medicine Myelodysplastic Syndrome Non Small Cell Lung Cancer Organ Systems Orphan Drug Signal Transduction Small Molecule Therapies Treatment Of Cancer Achondroplasia Advanced Breast Cancer Advanced Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Protein Kinase Inhibitor stocks.

    Symbol Grade Name Weight
    IDNA C iShares Genomics Immunology and Healthcare ETF 5.83
    CNCR D Loncar Cancer Immunotherapy ETF 4.95
    XBI D SPDR S&P Biotech ETF 3.86
    BBP D BioShares Biotechnology Products Fund 3.41
    FBT D First Trust Amex Biotech Index Fund 3.13
    View all Protein Kinase Inhibitor ETFs...
    Compare ETFs
    Compare CNCR to BBP Compare IDNA to CNCR Compare XBI to BBP

        Protein Kinase Inhibitor Stocks Recent News

        Date Stock Title
        May 13 COGT We Think Cogent Biosciences (NASDAQ:COGT) Can Afford To Drive Business Growth
        May 13 BBIO BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at ESC-HF, Including That Acoramidis Treatment Significantly Reduced All-Cause Mortality in a Pre-specified Sen...
        May 12 EXEL Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
        May 12 BBIO Cantor picks 14 undervalued biotech stocks worth a second look
        May 12 ACLX Arcellx First Quarter 2024 Earnings: Beats Expectations
        May 11 EXEL Exelixis files patent suit against India’s Cipla over Cabometyx generics
        May 10 ACLX Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
        May 10 ACLX Arcellx GAAP EPS of -$0.14, revenue of $39.3M
        May 10 ACLX Kite and Arcellx prepare to launch Phase III multiple myeloma trial
        May 9 ACLX Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
        May 9 ACLX Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
        May 9 ACLX Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 ACLX Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 NTBL Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024
        May 9 ACLX Arcellx Provides First Quarter 2024 Financial Results
        May 9 PRLD Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
        May 8 AVBP ArriVent BioPharma reports Q1 results
        May 8 AVBP ArriVent BioPharma Reports First Quarter 2024 Financial Results
        May 7 EXEL Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
        May 7 ACLX Arcellx to Participate in Two Upcoming Investor Conferences
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Tyrosine Kinase Biotechnology Biopharmaceutical Enzymes Solid Tumors Tyrosine Kinase Receptors Acute Myeloid Leukemia Cancer Treatment Clinical Medicine Myelodysplastic Syndrome Non Small Cell Lung Cancer Organ Systems Orphan Drug Signal Transduction Small Molecule Therapies Treatment Of Cancer Achondroplasia Advanced Breast Cancer Advanced Cancer
        Protein Kinase Inhibitor

        Protein kinase inhibitors are drugs that block the activity of one or more protein kinases. Protein kinases are enzymes that add phosphate groups to proteins, which can alter their activity and function. Protein kinase inhibitors are used to treat a variety of diseases, including cancer, inflammation, and autoimmune disorders.

        Browse All Tags